logo
logo
Sign in

Cerebrospinal Fluid Management Devices Market - Factors Driving Growth Post 2027

avatar
Depp Gaikwad

Cerebrospinal Fluid Management Devices Market Analysis

The Cerebrospinal Fluid Management (CSF) Devices market is growing pervasively. The market growth attributes to the rising prevalence of various neurological diseases and disorders. CSF devices are primarily used in the treatment of hydrocephalus, a condition that refers to the accumulation of cerebrospinal fluid (CSF) in the brain.  Hence, the growing awareness for this condition is also a significant factor that, along with the adoption of advanced and minimally invasive treatment procedures, escalates the market growth to furthered height.

According to Market Research Future (MRFR), the global cerebrospinal fluid management (CSF) devices market is estimated to grow at approx. 4.5% CAGR during the forecast period (2018 -2023). Also, factors such as the growing geriatric population and awareness about hydrocephalus propel the growth of the market. Simultaneously, the increasing prevalence of hydrocephalus in children boosts the market growth to an extent. Also, several risk factors leading to neurological disorders are creating enormous market demand.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7196

Additionally, increasing government funding and programs to support the R&D activities required for the development of CSF devices substantiate market growth. Furthermore, technological advances in the field of smart and connected devices, alongside the uses of some ubiquitous technologies such as Artificial Intelligence (AI) and the Internet of Things (IoT) to better diagnostic and treatment methods foster the market growth.

Conversely, factors such as the lack of trained professionals and side-effects associated with the treatment are projected to obstruct the market growth in years to come. Also, the high cost of CSF devices and lack of awareness for Hydrocephalus condition, act as major growth impeders for the market growth, especially in underdeveloped regions. Nevertheless, product launches of cost-competitive CSF devices would support the market growth throughout the anticipated period, filling the demand-supply gap. 

Global CSF Devices Market- Segments

The report is segmented into four dynamics;

By Product: Shunts (Ventriculoperitoneal (VP), Ventriculoatrial (VA), Lumboperitoneal (LP), Ventriculopleural (VPL), others), Valve (Fixed and Adjustable), External Drainage Systems (External Ventricular Drainage (EVD) Systems, Lumbar Drainage (LD) Systems, others), and others.

By Age GroupPediatric, Adult, and Geriatric.

By End UserHospitals, Ambulatory Settings, Clinics, Research & Academic Institutes, and others.

By Regions:  Americas, Europe, Asia Pacific, and Rest-of-the-World.

Cerebrospinal Fluid Management Devices Market - Regional Analysis

North America dominates the global cerebrospinal fluid management devices market. The largest market share attributes to the strong presence of notable market players and a large base of patients suffering from various neurological diseases & disorders. Besides, the early uptake of technologically advanced medical devices for the treatment of the growing prevalence of neurological disorders in children and adults drive the regional market growth.

Furthermore, factors such as the increasing R&D support by the governments and high expenditures in neurological care substantiate the market growth. The North American CSF devices market is estimated to retain its dominance over the global market throughout the forecast period.

Europe stands second in the global cerebrospinal fluid management devices market. Growth is driven by rising research and development investments and increasing technological advancements. Moreover, factors such as the increasing incidents of neurological disorders and focus on the development of advent diagnostic devices contribute to the regional market growth. Also, rising government support for R&D activities, alongside the increasing numbers of specialty services offered by various healthcare providers in the region fosters market growth.

Asia Pacific is an emerging market for cerebrospinal fluid management devices. Factors such as increased healthcare expenditures and rising cases of hydrocephalus drive the growth of the regional market. Additionally, growing occurrences of neurological disorders in the region, fuel the market growth.  Furthermore, augmenting demand for quality devices to treat neurological diseases & disorders and penetration of healthcare technology provide impetus to the regional market growth, leading to increasing the uptake of CSF devices. 

Global Cerebrospinal Fluid Management Devices Market- Competitive Analysis

Highly competitive, the CSF devices market appears fragmented, with a large number of players in the market churning the competition. Increasing incidences of drug resistance have opened doors for new entrants and leaders' development of new devices and opportunities. The rise of spurious and counterfeit devices has reduced the total market revenues, displacing standard devices off the market.

Cerebrospinal Fluid Management Devices Market Major Players:

Players leading the CSF devices market include Integra LifeSciences Holdings Corporation, Medtronic plc, B. Braun Melsungen AG, Spiegelberg GmbH & Co. KG, DePuy Synthes, SOPHYSA, Dispomedica GmbH, Natus Medical Incorporated, Delta Surgical Limited, Moller Medical GmbH, Argi Grup, G. SURGIWEAR LTD., BeckerSmith Medical, Inc., and Wellong Instruments Co., Ltd., among others.

Cerebrospinal Fluid Management Devices Industry/Innovations/Related News:

May 15, 2020 ---- Aesculap, Inc. (Germany), a leading medical device manufacturer, and its partner The Christoph Miethke GmbH & Co. KG (MIETHKE - Germany), launched the M.blue valve, the latest generation of Hydrocephalus valve technology in the US. The unique gravitational technology is integrated with a fixed differential pressure unit in one valve, allowing for a simple, position-dependent solution.

Aesculap, Inc. is a B. Braun company, the world's largest manufacturers of surgical instruments, medical devices, and sterilization container systems. The MIETHKE develops, produces, and distributes innovative neurosurgical products for the treatment of hydrocephalus. The partnership demonstrates an impactful collaborative effort to bring better Hydrocephalus solutions to patients, such as the new M.blue valve.

 

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/cerebrospinal-fluid-management-devices-market-7196

collect
0
avatar
Depp Gaikwad
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more